Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration
Sean K. Wang, … , Yunlu Xue, Constance L. Cepko
Sean K. Wang, … , Yunlu Xue, Constance L. Cepko
Published July 1, 2021
Citation Information: JCI Insight. 2021;6(16):e150796. https://doi.org/10.1172/jci.insight.150796.
View: Text | PDF
Research Article Ophthalmology Therapeutics

Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration

  • Text
  • PDF
Abstract

Inherited retinal diseases, such as retinitis pigmentosa (RP), can be caused by thousands of different mutations, a small number of which have been successfully treated with gene replacement. However, this approach has yet to scale and may not be feasible in many cases, highlighting the need for interventions that could benefit more patients. Here, we found that microglial phagocytosis is upregulated during cone degeneration in RP, suggesting that expression of “don’t-eat-me” signals such as CD47 might confer protection to cones. To test this, we delivered an adeno-associated viral (AAV) vector expressing CD47 on cones, which promoted cone survival in 3 mouse models of RP and preserved visual function. Cone rescue with CD47 required a known interacting protein, signal regulatory protein α (SIRPα), but not an alternative interacting protein, thrombospondin-1 (TSP1). Despite the correlation between increased microglial phagocytosis and cone death, microglia were dispensable for the prosurvival activity of CD47, suggesting that CD47 interacts with SIRPα on nonmicroglial cells to alleviate degeneration. These findings establish augmentation of CD47/SIRPα signaling as a potential treatment strategy for RP and possibly other forms of neurodegeneration.

Authors

Sean K. Wang, Yunlu Xue, Constance L. Cepko

×

Figure 3

Effect of CD47 expression on long-term cone survival and visual function.

Options: View larger image (or click on image) Download as PowerPoint
Effect of CD47 expression on long-term cone survival and visual function...
(A) Representative flat mounts of P130 rd10 retinas following infection with AAV8-RedO-GFP or AAV8-RedO-GFP plus AAV8-RedO-CD47. Paired images depict low- and high-magnification views. Scale bars: 1 mm. (B) Representative flat mounts of P150 Rho–/– retinas following infection with AAV8-RedO-GFP or AAV8-RedO-GFP plus AAV8-RedO-CD47. Paired images depict low- and high-magnification views. Scale bars: 1 mm. (C) Quantification of GFP-positive cones in central retinas of rd10 (n = 20) and Rho–/– (n = 18) mice following infection with AAV8-RedO-GFP or AAV8-RedO-GFP plus AAV8-RedO-CD47. (D) Percentage time spent in dark in a 50:50 light-dark box for untreated (n = 7–10) and rd1 (n = 11–13) mice following infection with AAV8-RedO-GFP or AAV8-RedO-GFP plus AAV8-RedO-CD47. (E) Visual thresholds in eyes from P60 rd10 mice (n = 19), as measured by optomotor following infection with AAV8-RedO-GFP or AAV8-RedO-GFP plus AAV8-RedO-CD47. Data are shown as mean ± SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001 by (C and E) 2-tailed Student’s t test and (D) 2-tailed Student’s t test with Bonferroni correction.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts